The financial crisis and increasing regulatory restrictions make the pharma industry a tough battleground. GSK’s Keith Allen tells NGP why innovative processes in the manufacturing line and ensuring regulatory harmony will create the winners in the industry.
Wouldn’t it be nice if the pharmaceutical supply chain could comply with cold chain regulations from manufacture to end-user? By Jean Bédard, Alternatives Technologie Pharma Inc.
Richard Malcolm of Acurian explains how to get the best ROI in patient recruitment.
By The Missouri Partnership. Missouri is offering incentives, a highly trained tech workforce and a supportive environment for pharmaceutical companies looking to expand or start up.